During the corresponding time, Orchestra Biomed Holdings Inc saw a revenue deteriorated by -89.47 % year on year, sequentially revenue fell by -20 %. While revenue at the Orchestra Biomed Holdings Inc 's corporate clients
Orchestra Biomed Holdings Inc's Comment on Sales, Marketing and Customers
The company operates through its subsidiary, FreeHold Surgical, serving early adopter hospitals and selective closed systems, including the U.S. Veterans Affairs hospital system. The Pure-Vu® System's workstation is manufactured by Sanmina Corporation in Israel, while its disposable components are produced by Sterling Industries in Michigan. The company also partners with a U.S.-based third-party logistics provider specializing in medical devices. Competitors in the interventional cardiology sector include Abbott Laboratories, B. Braun, Balton, Becton Dickinson, Biosensors International Group, Ltd., BIOTRONIK, Inc., Boston Scientific Corporation, Concept Medical, Inc., Cordis, Eurocor Tech GmbH, Invamed, Inc., iVascular, S.L.U., Medtronic plc, MicroPort, Philips N.V., and Teleflex, Inc. In the cardiac rhythm management devices field, competitors include Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK, Inc., and MicroPort CRM.
News about Orchestra Biomed Holdings Inc Contracts
Orchestra BioMed Holdings, an innovative biomedical company, has announced that it will be hosting an exclusive in-person Research and Development (RandD) day on June 11, 2024, at the prestigious Lotte New York Palace Hotel. The event will provide a platform for Orchestra BioMed to showcase their pioneering AVIM Therapy Program, specifically designed for hypertensive pacemaker patients.With a commitment to accelerating high-impact technologies for patients, Orchestra BioMed aims to revolutionize the treatment landscape through risk-reward sharing partnerships. Their AVIM Therapy Program stands as a testament to this mission, offering hope to individuals suffering from hypertension in conjunction with pacemak...
- Hypertension remains a significant global health concern, affecting millions of individuals worldwide.- Conventional pharmacological therapies for hypertension may not always effectively control blood pressure in certain patient populations, including those with pacemakers.- Orchestra BioMed Holdings, Inc. has initiated the BACKBEAT pivotal study to evaluate the potential of atrioventricular interval modulation (AVIM) therapy, also known as BackBeat CNT, in treating pacemaker-indicated patients with uncontrolled hypertension.Section 1: Background and Rationale:- Discuss the prevalence and impact of hypertension on overall health and cardiovascular outcomes.- Highlight the challenges faced by pacemaker pati...
Orchestra Biomed Holdings Inc’s Comment on Sales, Marketing and Customers
The company operates through its subsidiary, FreeHold Surgical, serving early adopter hospitals and selective closed systems, including the U.S. Veterans Affairs hospital system. The Pure-Vu® System's workstation is manufactured by Sanmina Corporation in Israel, while its disposable components are produced by Sterling Industries in Michigan. The company also partners with a U.S.-based third-party logistics provider specializing in medical devices. Competitors in the interventional cardiology sector include Abbott Laboratories, B. Braun, Balton, Becton Dickinson, Biosensors International Group, Ltd., BIOTRONIK, Inc., Boston Scientific Corporation, Concept Medical, Inc., Cordis, Eurocor Tech GmbH, Invamed, Inc., iVascular, S.L.U., Medtronic plc, MicroPort, Philips N.V., and Teleflex, Inc. In the cardiac rhythm management devices field, competitors include Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK, Inc., and MicroPort CRM.
Sources:
Orchestra Biomed Holdings Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Orchestra Biomed Holdings Inc’s corporate clients.
For your research, we’ve provided 9 tables on Orchestra Biomed Holdings Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
225 %